Average Co-Inventor Count = 4.32
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance, Inc. (60 from 386 patents)
2. Theravance Biopharma R&d Ip, LLC (42 from 262 patents)
3. Praxis Bioresearch, LLC (2 from 2 patents)
104 patents:
1. 12398135 - Dimethyl amino azetidine amides as JAK inhibitors
2. 11919836 - Prodrugs of fencamfamine
3. 11845747 - Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
4. 11713315 - 5 to 7 membered heterocyclic amides as JAK inhibitors
5. 11634419 - Dimethyl amino azetidine amides as JAK inhibitors
6. 11608354 - Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
7. 11548887 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
8. 11155549 - Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
9. 10961267 - Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
10. 10947229 - Dimethyl amino azetidine amides as JAK inhibitors
11. 10836763 - 5 to 7 membered heterocyclic amides as JAK inhibitors
12. 10745394 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
13. 10745405 - Glucuronide prodrugs of Janus kinase inhibitors
14. 10662146 - Prodrugs of fencamfamine
15. 10472366 - Glucuronide prodrugs of tofacitinib